Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanitizers Drive 2020 US OTC Drug Recalls To Double 2019 Total

Mar 03 2021

• By Eileen Francis

Related Content

Online Pharmacy Stirs Ranitidine Controversy With Petition To Halt Sales

Sep 15 2019

US FDA Requests Ranitidine Removal But Also Encourages Research For Stable Formulations

Apr 02 2020

Guidance Opening Sanitizer Production Stirs Firms Including Anheuser-Busch, Dow, Kodak

Apr 02 2020

Perrigo's Recall Flushes Ranitidine OTC Private Label And Store Brand Products From US Market

May 04 2020

After Finding Nitrosamine In Ranitidine, US Firm Suggests Link To Higher Cancer Diagnosis Rates

Jan 29 2021

Preparing For The Return Of US FDA Inspections

Feb 15 2021

US Seizes More Contaminated OTC Sanitizers From Mexico, Plus Subpotent Product From China

Feb 11 2021

Additional Topics

International United States Mexico OTC Drugs Recalls FDA Commercial Compliance Coronavirus COVID-19 Manufacturing Enforcement Distribution Regulation Policy Safety Consumer

More from Recalls

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window